Yahoo
NYSE - Delayed Quote USD

Novartis AG (NVS)

159.99 -3.10 (-1.90%)
At close: September 4 at 4:00:02 PM EDT
162.90 +2.91 (+1.82%)
After hours: September 4 at 7:58:19 PM EDT
Trade NVS on Coinbase

News headlines

Updated 8m ago
Powered by Yahoo Scout

Novartis faced significant setbacks as its Phase 3 trial for pelacarsen failed to meet primary endpoints, impacting its stock performance. Despite this, Novartis is pushing forward with other pipeline projects and strategic initiatives, including a $3.2 billion deal with Alteogen.

Mobilize your Website
View Site in Mobile | Classic
Share by: